DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Kellton Tech Solutions Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·16 Oct 2026, 11:02 am

Kellton Tech Solutions

Kellton Tech Solutions Limited has informed the stock exchanges about the issuance of a certificate under SEBI's (Depositories and Participants) Regulations, 2018. This regulatory filing confirms that the company has successfully complied with the requirements for maintaining a valid Depository Participant (DP) license.

This development is a routine corporate compliance matter and does not indicate any operational or financial distress. For investors, it serves as a positive signal regarding the company's adherence to regulatory standards. It ensures that the company's shareholding process remains uninterrupted and transparent.

Investors should monitor the company's future quarterly results to see if this regulatory compliance translates into improved operational performance. The stock's movement will likely depend more on its core business metrics than on this specific regulatory update.